Summary

Eligibility
for people ages 18-65 (full criteria)
Location
at San Diego, California
Dates
study started
estimated completion
Principal Investigator
Dawn M Eichen, PhD

Description

Summary

Binge Eating Disorder (BED) is the most common eating disorder, and currently, the best behavioral treatments only work for 40-60% of adults. BED often co-occurs with mood and anxiety disorders, and both are associated with neurocognitive deficits related to executive function (EF). These EF deficits contribute to worsening BED symptoms and make it difficult for these adults to adhere to treatment recommendations. The proposed study aims to develop an EF training enhanced behavioral treatment for BED and compare its effectiveness to the standard cognitive behavioral therapy for patients with BED and a co-occurring mood or anxiety disorder.

Official Title

Executive Function Training for Binge Eating Disorder and Comorbid Mood/Anxiety Disorders

Details

A randomized controlled trial (RCT) will evaluate an EF training enhanced cognitive behavioral therapy (CBT) for BED (EF-BED+CBT) compared to standard CBT in patients with BED and a comorbid mood/anxiety disorder to assess the feasibility, acceptability, and preliminary efficacy of EF-BED+CBT in reducing binge eating, impairment, and comorbid depression/anxiety symptoms. Adult participants with BED and comorbid mood/anxiety disorder will be randomized to a four month remote treatment of either EF-BED+CBT or CBT alone. Participants will be assessed at baseline, following treatment (month 4) and 2-month follow-up (month 6).

Keywords

Binge-Eating Disorder Binge Eating Anxiety Disorders Mood Disorders Disease Bulimia Feeding and Eating Disorders Executive Function- Enhanced CBT for BED (EF-BED+CBT) Cognitive Behavioral Therapy (CBT)

Eligibility

You can join if…

Open to people ages 18-65

  • Age 18-65
  • Ability to read English at a 6th grade level
  • Clinical or subclinical BED and at least one comorbid mood or anxiety disorder

You CAN'T join if...

  • Known cognitive disability (e.g., brain injury with loss of consciousness >30 min, intellectual disability)
  • Psychosis
  • Psychiatric condition that could interfere with program participation (e.g., substance abuse, suicide attempt within previous 6 months, active purging, active suicidality)
  • Currently pregnant, lactating or plan to be in the timespan of program follow-up
  • Change in psychotropic medication or other medication that could have impact on weight, binge eating or anxiety/mood symptoms during the previous 3 months
  • Participating in an organized program for overeating

Location

  • Ucsd Chear accepting new patients
    San Diego California 92037 United States

Lead Scientist at UCSD

  • Dawn M Eichen, PhD
    Assistant Adjunct Professor, Pediatrics. Authored (or co-authored) 34 research publications.

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
University of California, San Diego
ID
NCT04242550
Study Type
Interventional
Last Updated